|
|
 |
|
Viewing report
|
|
|
|
Isis Pharmaceuticals, Inc. - SWOT Analysis
MarketLine, Dec 2011, Pages: 23
Isis Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Isis Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Isis Pharmaceuticals (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. The company's principal activity is to develop and market RNA-based drugs for the treatment of cardiovascular diseases, metabolic, inflammatory and cancer diseases. The company primarily operates in the US. Isis is headquartered in Carlsbad, California and employed 270 people as of February 14, 2011. The company recorded revenues of $108.5 million during the financial year (FY) ended December 2010, a decrease of 10.8% over FY2009. The operating loss of the company was $48.4 million during FY2010, as compared with an operating loss of $27.5 million in FY2009. The net loss was $61.3 million in FY2010, as compared with a net profit of $155.1 million in FY2009.
Scope of the Report
- Provides all the crucial information on Isis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Isis Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Isis Pharmaceuticals, Inc.
-Data is supplemented with details on Isis Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Isis Pharmaceuticals, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
